Skip to main content

Advertisement

Table 1 Effect of lycopene (1-5 μM) on cell cycle progression in different human cancer cell lines after 48 hours

From: Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines

Cell Lines Cell Cyle phases CT 1 μM 3 μM 5 μM
HT-29 G0/G1 47.40 ± 0.57 61.65 ± 3.61* 55.10 ± 1.41* 59.05 ± 7.42*
S 21.30 ± 4.53 19.70 ± 0.42 19.75 ± 0.49 20.70 ± 0.85
G2/M 18.55 ± 3.61 13.70 ± 1.84 18.90 ± 0.42 12.45 ± 3.18
T84 G0/G1 42.20 ± 0.39 40.31 ± 0.40 41.10 ± 0.71 44.96 ± 2.76*
S 10.93 ± 0.13 11.90 ± 0.60 10.25 ± 1.07 10.60 ± 0.45
G2/M 33.00 ± 0.09 35.03 ± 1.74 33.90 ± 0.88 31.53 ± 0.81*
MCF-7 G0/G1 29.45 ± 2.05 29.15 ± 1.48 32.65 ± 0.49* 33.20 ± 1.13*
S 17.00 ± 4.24 18.05 ± 2.90 16.75 ± 3.18 17.35 ± 0.92
G2/M 36.50 ± 0.71 34.50 ± 0.71 16.90 ± 1.27* 22.40 ± 1.98*
A549 G0/G1 55.64 ± 0.28 57.84 ± 0.77 56.34 ± 0.14 58.82 ± 0.33*
S 14.85 ± 0.05 13.99 ± 0.16 14.32 ± 0.23 13.43 ± 0.45
G2/M 31.01 ± 0.28 29.58 ± 0.73 30.82 ± 0.02 28.86 ± 0.81
DU145 G0/G1 47.73 ± 2.21 48.49 ± 0.81 46.46 ± 4.21 56.14 ± 1.33*
S 13.52 ± 1.12 12.46 ± 0.44 11.47 ± 1.27 9.10 ± 0.76
G2/M 36.76 ± 0.76 36.24 ± 0.35 36.14 ± 1.61 31.20 ± 0.54*
HepG2 G0/G1 28.70 ± 2.40 29.75 ± 0.35 25.20 ± 2.55 28.45 ± 0.78
S 17.80 ± 2.55 16.85 ± 0.21 16.20 ± 1.70 16.20 ± 1.13
G2/M 27.95 ± 1.34 26.82 ± 0.99 25.30 ± 4.53 25.70 ± 1.84
Hela G0/G1 62.42 ± 0.31 62.48 ± 0.08 63.49 ± 1.33 63.59 ± 2.26
S 10.35 ± 0.28 9.02 ± 0.59 8.19 ± 0.24 7.86 ± 0.33
G2/M 25.87 ± 0.27 26.36 ± 0.28 24.90 ± 0.32 26.19 ± 0.12
Hep2 G0/G1 64.80 ± 0.25 67.02 ± 0.54 66.98 ± 0.00 63.97 ± 0.50
S 6.83 ± 0.05 6.75 ± 0.38 7.31 ± 0.08 7.48 ± 0.72
G2/M 28.56 ± 0.20 26.45 ± 0.66 26.98 ± 1.28 28.99 ± 0.16
  1. Results are expressed as the percentage of total cells. Data represent mean ± SD values of triplicate experiments. Tukey–Kramer Multiple Comparison test; *p < 0.05; **p < 0.01